SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Trollfors B.)
 

Sökning: WFRF:(Trollfors B.) > The diphtheria and ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003110naa a2200469 4500
001oai:gup.ub.gu.se/52822
003SwePub
008240528s2005 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/528222 URI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Robbins, J. B.4 aut
2451 0a The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins
264 1c 2005
520 a Replacement of cellular with acellular pertussis (aP) vaccines has considerably reduced the systemic reactions observed with diphtheria-tetanus toxoids-pertussis vaccine but has not eliminated the extensive swelling (sometimes involving an entire limb) observed after the fifth injection of diphtheria-tetanus toxoids-aP (DTaP) vaccine. This local reaction, which is likely an Arthus hypersensitivity reaction caused by high levels of antibodies reacting with DTaP vaccine, could discourage its use in adults, who serve as the major reservoir of pertussis for infants. That a critical level of antibodies to pertussis toxin is both essential and sufficient to prevent infection with Bordetella pertussis is derived from data from animal and clinical studies, including data showing the similarities between the immunity induced by diphtheria and pertussis toxoids. The genetically inactivated diphtheria and pertussis mutant toxins are more immunogenic and, therefore, induce comparable levels of antitoxin at lower protein levels than do the formalin-treated native toxins. Replacement of the diphtheria and aP components with these improved antigens will reduce the amount of protein in DTaP vaccine and, most likely, the incidence and severity of local reactions in teenagers and adults.
653 a Adult
653 a Arthus Reaction/etiology
653 a Child
653 a Clinical Trials
653 a Diphtheria/prevention & control
653 a Diphtheria Toxin/*genetics/immunology
653 a Diphtheria-Tetanus-acellular Pertussis Vaccines/*adverse
653 a effects/*immunology
653 a Humans
653 a Infant
653 a Mutation
653 a Pertussis Toxin/*genetics/immunology
653 a Tetanus/prevention & control
653 a Vaccination
653 a Whooping Cough/epidemiology/prevention & control
700a Schneerson, R.4 aut
700a Trollfors, Birger,d 1947u Gothenburg University,Göteborgs universitet,Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik,Institute for the Health of Women and Children, Dept of Paediatrics4 aut0 (Swepub:gu)xtrobi
700a Sato, H.4 aut
700a Sato, Y.4 aut
700a Rappuoli, R.4 aut
700a Keith, J. M.4 aut
710a Göteborgs universitetb Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik4 org
773t J Infect Disg 191:1, s. 81-8q 191:1<81-8x 0022-1899
8564 8u https://gup.ub.gu.se/publication/52822

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy